Tolerability of immune checkpoint inhibitors in patients with cancer and pre-existing multiple sclerosis
ContributorsChavaz, Lara Marie
Published inEuropean journal of cancer, vol. 189, 112928
Publication date2023-06-13
First online date2023-06-13
Abstract
Keywords
- Antineoplastic Agents, Immunological / adverse effects
- Humans
- Immune Checkpoint Inhibitors / adverse effects
- Multiple Sclerosis / drug therapy
- Neoplasms / drug therapy
Affiliation entities Not a UNIGE publication
Citation (ISO format)
CHAVAZ, Lara Marie et al. Tolerability of immune checkpoint inhibitors in patients with cancer and pre-existing multiple sclerosis. In: European journal of cancer, 2023, vol. 189, p. 112928. doi: 10.1016/j.ejca.2023.05.016
Main files (1)
Article (Published version)
Identifiers
- PID : unige:186394
- DOI : 10.1016/j.ejca.2023.05.016
- PMID : 37320934
Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S0959804923002551
Journal ISSN0959-8049
